Oxidative stress biomarkers don't always signal diabetes risk

August 7, 2017, Georgia State University
Credit: Georgia State University

High levels of compounds found in the body that are commonly associated with oxidative damage may actually be a good sign for some people, according to a recent review of multiple human studies led by an epidemiologist at the School of Public Health at Georgia State University.

Compounds known as F2-isoprostanes are conventionally interpreted as indicators or "biomarkers" of harmful oxidative stress detectable in human tissues and bodily fluids, researchers stated. These molecules are footprints of highly reactive free radicals, which are mainly formed in normal processes of energy metabolism.

"It has been hypothesized that elevated F2-isoprostane levels—as biomarkers of oxidative stress—will predict increased risk of type 2 ," the researchers said. But the hypothesis didn't hold true when the risk of diabetes was examined in a multi-ethnic study group. The study found that elevated levels of F2-isoprostanes are associated with a reduced risk of diabetes. Researchers explained their results by connecting elevated F2-isoprostane levels to the intensity of energy metabolism, which is known to be protective against and type 2 diabetes. The study also discovered racial differences in F2-isoprostanes.

While African-Americans are at increased risk of developing obesity and type 2 diabetes, they generally have lower levels of F2-isoprostanes, the researchers noted in their review. They also noted a study conducted among Atlanta's West African Immigrants, African Americans, and non-Hispanic Whites, which clearly demonstrated that African ancestry is associated with lower F2-isoprostane levels.

The researchers also analyzed studies that pointed to an association between increased F2-isoprostane levels and physical exercise—an intervention against developing obesity and type 2 diabetes.

"As African Americans show lower systemic levels of F2-isoprostanes, using these non-invasive biomarkers can enable the development of pharmacological and/or life style interventions targeted to the reduction of metabolic risks among African Americans," the researchers said.

Their review summarized 132 publications focused on in predisposition to obesity and type 2 diabetes in the United States and global research on F2-isoprostanes and human health; these studies ranged from socioeconomic and environmental factors determining racial disparities to human molecular studies on F2-isoprostanes.

The researchers' findings are published in Diversity and Equality in Health and Care in the review article "Systemic F2-Isopropstane Levels in Predisposition to Obesity and Type 2 Diabetes: Emphasis on Racial Differences." The article's lead author is Dr. Dora Il'yasova, associate professor of epidemiology and biostatistics at Georgia State.

Explore further: Aspirin enhances platelet isoprostanes in type 2 diabetes

More information: SystemicF2-Isoprostane Levels in Predisposition to Obesity and Type 2 Diabetes: Emphasis on Racial Differences. Diversity and Equality in Health and Care. diversityhealthcare.imedpub.co … fferences-18823.html

Related Stories

Aspirin enhances platelet isoprostanes in type 2 diabetes

March 23, 2012
(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) who are treated with aspirin, isoprostanes are overproduced, which is linked with enhanced platelet recruitment, according to a study published online March ...

Non-traditional risk factors illuminate racial disparities in type 2 diabetes

February 6, 2014
(Medical Xpress)—Two surprising risk factors – diminished lung function and low serum potassium levels - appear to have nearly the same impact as obesity in explaining why African-Americans are disproportionately prone ...

Race ranks higher than pounds in diabetes, heart-health risks

April 3, 2017
Americans of South Asian descent are twice as likely as whites to have risks for heart disease, stroke and diabetes, when their weight is in the normal range, according to a study headed by Emory University and UC San Francisco.

Link between racial discrimination and stress described in new study

September 14, 2011
The consequences of psychological stress, resulting from racial discrimination, may contribute to racial health disparities in conditions such as cardiovascular disease, diabetes and other age-associated diseases. This is ...

Serum trypsinogen levels down in type 1 diabetes

January 26, 2017
(HealthDay)—Patients with type 1 diabetes have significantly lower serum trypsinogen levels than those without type 1 diabetes, according to a study published online Jan. 23 in Diabetes Care.

Recommended for you

Belly fat promotes diabetes under orders from liver

March 21, 2018
The fat that builds up deep in the abdomen—more than any other type of body fat—raises the risk of insulin resistance and type 2 diabetes. Researchers have known that abdominal fat becomes dangerous when it becomes inflamed ...

Consuming low-calorie sweeteners may predispose overweight individuals to diabetes

March 18, 2018
Consumption of low-calorie sweeteners could promote metabolic syndrome and predispose people to prediabetes and diabetes, particularly in individuals with obesity, a new study on human fat-derived stem cells and fat samples ...

Are high blood glucose levels an effect rather than the cause of diabetes?

March 15, 2018
Insulin resistance and elevated blood glucose levels are considered to be the cause of type 2 diabetes. However, scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital have now provided ...

Smoking linked with higher risk of type 2 diabetes

March 15, 2018
The prevalence of diabetes has increased almost 10-fold in China since the early 1980s, with one in 10 adults in China now affected by diabetes. Although adiposity is the major modifiable risk factor for diabetes, other research ...

Social support and machine learning are at the core of a student-developed app for people with diabetes

March 14, 2018
Diabetes is the seventh leading cause of death in the U.S., and nearly 10 percent of the population suffers from this chronic disease, according to the Centers for Disease Control and Prevention.

Toxic proteins and type 2 diabetes

March 9, 2018
Nearly a half-billion people worldwide live with type 2 diabetes. Yet despite the disease's sizeable and increasing impact, its precise causes remain murky. Current scientific thinking points to two key processes: insulin ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.